Seggewiss Hubert
Leopoldina-Krankenhaus, Schweinfurt, Germany.
Curr Control Trials Cardiovasc Med. 2000;1(2):115-119. doi: 10.1186/cvm-1-2-115.
Medical treatment in symptomatic patients with hypertrophic obstructive cardiomyopathy aims to reduce the outflow tract gradients, and to improve diastolic dysfunction and rhythm disorders. Surgical myectomy is the standard treatment in patients with drug refractory symptoms. Since the early 1990s, dual-chamber (DDD)-pacemaker implantation and percutaneous transluminal septal myocardial ablation by alcohol-induced septal branch occlusion have widened treatment options in this subgroup of patients. An overview of medical and interventional treatment is presented.